Mackenzie Financial Corp Sells 256,629 Shares of Amedisys, Inc. (NASDAQ:AMED)

Mackenzie Financial Corp cut its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 36.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 437,964 shares of the health services provider's stock after selling 256,629 shares during the period. Mackenzie Financial Corp owned about 1.34% of Amedisys worth $39,763,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in AMED. Public Employees Retirement System of Ohio bought a new position in shares of Amedisys during the fourth quarter valued at $1,869,000. Vise Technologies Inc. bought a new stake in shares of Amedisys in the fourth quarter worth $248,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Amedisys by 11.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 101,752 shares of the health services provider's stock valued at $9,238,000 after purchasing an additional 10,105 shares during the period. Squarepoint Ops LLC raised its position in Amedisys by 2.3% during the 4th quarter. Squarepoint Ops LLC now owns 186,379 shares of the health services provider's stock worth $16,921,000 after purchasing an additional 4,158 shares during the last quarter. Finally, Two Sigma Advisers LP raised its position in Amedisys by 151.9% during the 4th quarter. Two Sigma Advisers LP now owns 13,600 shares of the health services provider's stock worth $1,235,000 after purchasing an additional 8,200 shares during the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have commented on AMED shares. Stephens reiterated an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research report on Tuesday, March 4th. Wall Street Zen cut Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research report on Wednesday, April 16th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Amedisys presently has an average rating of "Hold" and an average price target of $100.75.

Amedisys Stock Up 0.3%

NASDAQ:AMED traded up $0.28 on Friday, hitting $94.22. The stock had a trading volume of 46,940 shares, compared to its average volume of 413,050. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The business's fifty day moving average is $93.44 and its 200 day moving average is $91.55. The company has a market cap of $3.09 billion, a PE ratio of 37.39, a P/E/G ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $594.78 million for the quarter, compared to analyst estimates of $597.43 million. During the same period last year, the firm earned $1.03 earnings per share. The firm's revenue was up 4.1% on a year-over-year basis. On average, equities research analysts expect that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.